Back to LLY Stock Lookup

Eli Lilly & Co. (LLY) – StreetInsider.com Reports

May 27, 2015 08:31 AM Eli Lilly & Co. (LLY) Announces FDA Approval of Higher-Concentration Humalog KwikPen
May 15, 2015 02:16 PM Halvorsen's Viking Global Raises Google (GOOG), Micron (MU) Stakes; Sells Coca-Cola (KO), Wal-mart (WMT)
May 14, 2015 06:14 AM Eli Lilly & Co. (LLY), Sanford-Burnham to Collaborat on Immunotherapies
May 11, 2015 03:18 PM Eli Lilly & Co. (LLY), BioNTech Enter Immunotherapy Research Collaboration; Lilly to Make Investment
May 4, 2015 02:27 PM Eli Lilly & Co. (LLY) Declares $0.50 Quarterly Dividend; 2.7% Yield
May 1, 2015 10:17 AM Eli Lilly & Co. (LLY) Gains Amid Unconfirmed Takeover Chatter
Apr 29, 2015 10:47 AM Notable Analyst Rating Changes 4/29: (LLY) (VOD) (UPS) Upgraded; (GLW) (ETR) (NOV) Downgraded
Apr 29, 2015 09:58 AM UPDATE: Citi Upgrades Eli Lilly (LLY) to Buy
Apr 24, 2015 04:31 PM Eli Lilly's (LLY) CYRAMZA Approved for Use with FOLFIRI in 2nd Treatment of Metastatic Colorectal Cancer
Apr 23, 2015 06:26 AM Eli Lilly & Co. (LLY) Tops Q1 EPS by 11c
Apr 22, 2015 02:15 PM Trading Radar for 4/23: Microsoft (MSFT), Google (GOOG), Amazon (AMZN), 3M (MMM), Starbucks (SBUX) Report
Apr 20, 2015 09:01 AM Eli Lilly & Co.'s (LLY) Ixekizumab Phase 3 Met Primary Endpoint
Apr 16, 2015 12:35 PM Bristol-Myers Squibb (BMY) Sees non-Cash, Pretax Charges of $150M to $200M on Erbitux Deal
Apr 16, 2015 12:17 PM Eli Lilly & Co. (LLY) to Regain Erbitux North American Rights from Bristol-Myers Squibb (BMY)
Apr 10, 2015 11:07 AM Eli Lilly & Co. (LLY) Drug Gets Orphan Designation in Anal Cancer
Apr 2, 2015 08:32 AM OncoMed Pharma (OMED), Lilly Enter Collaboration for NSCLC Treatment
Mar 23, 2015 08:31 AM Eli Lilly & Co. (LLY) Annnounces Availability of Glyxambi Tabs
Mar 23, 2015 08:17 AM Pfizer (PFE), Eli Lilly (LLY) to Resume Phase 3 Chronic Pain Program For Tanezumab
Mar 19, 2015 08:04 AM Eli Lilly & Co. (LLY), Hanmi Pharma Enter HM71224 Development, Commercialization Agreement
Mar 16, 2015 07:18 AM Biodel (BIOD) Announces Study 6-101 Met Primary Endpoint
Mar 6, 2015 09:27 AM Eli Lilly & Co. (LLY) Receives Adverse Ruling in German Patent Suit
Mar 3, 2015 11:28 AM FDA Issues Drug Safety Communication Related to Testosterone Products
Feb 23, 2015 07:20 AM Eli Lilly & Co. (LLY), Incyte (INCY) Report Statistically Significant Data from Baricitinib Phase 3
Feb 19, 2015 08:03 AM Eli Lilly & Co. (LLY) to Extend Phase 3 Trial of Evacetrapib
Feb 19, 2015 08:02 AM Eli Lilly & Co. (LLY) Will Extend Evacetrapib Phase 3 by Six Months
Feb 2, 2015 08:40 AM Eli Lilly & Co. (LLY) Reports FDA Approval of Glyxambi in Type 2 Diabetes
Jan 30, 2015 06:25 AM Eli Lilly & Co. (LLY) Tops Q4 EPS by 1c; Trims FY15 Revs Outlook
Jan 29, 2015 01:59 PM Trading Radar for 1/30: MasterCard (MA), Altria (MO), Tyco (TYC), Lear (LEA), Xerox (XRX) Report
Jan 22, 2015 07:20 AM NICE Issues FAD on Jardiance as Type 2 Diabetes Treatment with NHS England (LLY)
Jan 15, 2015 07:03 AM Goldman Sachs Upgrades Eli Lilly (LLY) to Neutral
Jan 13, 2015 08:01 AM Merck (MRK), Lilly (LLY) Enter Collaboration for KEYTRUDA Combo
Jan 12, 2015 04:29 PM FBN's Maria Bartiromo to Anchor Live from 33rd Annual J.P. Morgan Healthcare Conference
Jan 9, 2015 03:55 PM Top 10 News for 1/5 - 1/9: Markets Ramp on Strong Dec. Jobs Numbers; Crude's Slide Continues; Peltz Gets Tough on DuPont
Jan 9, 2015 06:35 AM BofA/Merrill Lynch Downgrades Eli Lilly (LLY) to Neutral, Upside Priced In
Jan 8, 2015 07:23 AM Deutsche Bank Downgrades Eli Lilly (LLY) to Hold
Jan 8, 2015 06:50 AM Jefferies Upgrades Eli Lilly (LLY) to Buy
Jan 7, 2015 05:15 PM Market Wrap: Fed Doesn't See Rate Hike in Q1; Employment Shows Robust Expansion in Dec.; FHA Gets Rate Cut
Jan 7, 2015 07:32 AM Eli Lilly & Co. (LLY) Guides FY15 EPS Below Expectations
Jan 2, 2015 06:42 AM Eli Lilly & Co. (LLY) Completes $5.4B Acquisition of Novartis Animal Health
Dec 22, 2014 10:08 AM Eli Lilly & Co. (LLY), University of Surrey Enter Partnership for Type 2 Diabetes Treatment
Dec 19, 2014 07:21 AM Eli Lilly & Co. (LLY), Adocia Enter Global License for BioChaperone Lispro Development
Dec 16, 2014 02:48 PM Eli Lilly's (LLY) CYRAMZA Reaches Three-Approval Mark by FDA
Dec 15, 2014 04:30 PM Eli Lilly & Co. (LLY) Raises Quarterly Dividend 2% to $0.50; 2.9% Yield
Dec 12, 2014 12:49 PM Eli Lilly & Co. (LLY): FDA Expands Approved Use of Cyramza
Dec 11, 2014 11:30 AM Notable Analyst Rating Changes 12/11: (PLD) (JPM) (LLY) Upgraded; ARIA) (VRA) (ABBV) Downgraded
Dec 11, 2014 08:10 AM Morgan Stanley Upgrades Eli Lilly (LLY) to Overweight
Dec 9, 2014 07:33 AM Eli Lilly & Co. (LLY), Incyte (INCY) Report Phase 3 RA-BEACON Met Primary Endpoint
Dec 4, 2014 10:22 AM Jefferies Names Top 2015 Pharmaceutical Picks (PFE) (NVS) (more...)
Dec 1, 2014 07:03 AM Lilly & Co. (LLY), AstraZeneca (AZN) Enroll First Patient in AMARANTH
Nov 5, 2014 02:51 PM Lilly & Co. (LLY) Reports FDA Approval of CYRAMZA Combo as GEJ Adenocarcinoma Treatment

Back to LLY Stock Lookup